The combined SMD was − 0.22 (95% CI: − 1.43 to 0.98; z = 0.36, P = 0.72), which suggested that the level of serum osteocalcin in children with epilepsy was not affected by the long-term use of valproic acid (Fig. 4a). This evidence concerns the gene BGLAP and epilepsy.